Published in J Gastric Cancer on June 27, 2012
Hyperfibrinogenemia is associated with inflammatory mediators and poor prognosis in patients with gastric cancer. Surg Today (2016) 0.82
Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study. BMC Cancer (2016) 0.82
Usefulness of Preoperative Plasma Fibrinogen Versus Other Prognostic Markers for Predicting Gastric Cancer Recurrence. World J Surg (2016) 0.78
Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1. Oncotarget (2016) 0.77
Prognostic value of combined preoperative fibrinogen and neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma after liver transplantation. Oncotarget (2016) 0.76
Preoperative Plasma Fibrinogen Level Represents an Independent Prognostic Factor in a Chinese Cohort of Patients with Upper Tract Urothelial Carcinoma. PLoS One (2016) 0.76
Combined Fibrinogen and Neutrophil-Lymphocyte Ratio as a Prognostic Marker of Advanced Esophageal Squamous Cell Carcinoma. Cancer Sci (2016) 0.75
Clinical significance of coagulation factors in operable colorectal cancer. Oncol Lett (2017) 0.75
THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. Acta Pathol Microbiol Scand (1965) 22.65
Japanese Classification of Gastric Carcinoma - 2nd English Edition - Gastric Cancer (1998) 16.63
Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg (1998) 4.86
Gastric cancer. Lancet (2003) 3.96
Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood (2000) 2.78
Predictors of operative morbidity and mortality in gastric cancer surgery. Br J Surg (2005) 2.11
Fibrinogen. Int J Biochem Cell Biol (1999) 1.57
Developing an institutional protocol guideline for laparoscopy-assisted distal gastrectomy. Ann Surg Oncol (2009) 1.51
Pretreatment plasma fibrinogen level correlates with tumor progression and metastasis in patients with squamous cell carcinoma of the esophagus. J Gastroenterol Hepatol (2007) 1.46
Diagnostic accuracy of T and N stages with endoscopy, stomach protocol CT, and endoscopic ultrasonography in early gastric cancer. J Surg Oncol (2009) 1.26
Hydro-dynamic CT preoperative staging of gastric cancer: correlation with pathological findings. A prospective study of 107 cases. Eur Radiol (2000) 1.21
Hyperfibrinogenemia is associated with lymphatic as well as hematogenous metastasis and worse clinical outcome in T2 gastric cancer. BMC Cancer (2006) 1.18
Dedicated multidetector CT of the stomach: spectrum of diseases. Radiographics (2003) 1.10
Plasma fibrinogen and serum C-reactive protein are associated with non-small cell lung cancer. Lung Cancer (2006) 1.09
Aggressive surgical treatment for T4 gastric cancer. J Gastrointest Surg (2004) 1.06
Elevated levels of plasma fibrinogen in patients with pancreatic cancer: possible role of a distant metastasis predictor. Pancreas (2009) 1.05
Diagnostic accuracy of multidetector row computed tomography in T- and N staging of gastric cancer with histopathologic correlation. J Comput Assist Tomogr (2006) 1.00
Endoscopic ultrasound and computed tomography in restaging and predicting prognosis after neoadjuvant chemotherapy in patients with locally advanced gastric cancer. Cancer (2008) 1.00
Preoperative plasma fibrinogen levels in gastric cancer patients correlate with extent of tumor. Hepatogastroenterology (2004) 0.97
Fibrinogen deposition without thrombin generation in primary human breast cancer tissue. Cancer Res (1991) 0.96
Staging laparoscopy for advanced gastric cancer: is it also useful for the group which has an aggressive surgical strategy? World J Surg (2007) 0.94
Effect of preoperative hyperfibrinogenemia on recurrence of colorectal cancer without a systemic inflammatory response. World J Surg (2009) 0.90
Determinants of surgical morbidity in gastric cancer treatment. J Am Coll Surg (2008) 0.89
Prognostic significance of intraoperatively estimated surgical stage in curatively resected gastric cancer patients. J Am Coll Surg (2009) 0.83
Fibrinogen levels correlate with stage of disease in patients with oesophageal cancer. Br J Surg (1997) 0.81
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet (2012) 6.83
Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study. J Clin Oncol (2011) 6.18
Improved quality of life outcomes after laparoscopy-assisted distal gastrectomy for early gastric cancer: results of a prospective randomized clinical trial. Ann Surg (2008) 4.95
Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring. JAMA (2004) 4.63
C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study. Arch Intern Med (2005) 3.31
Randomized clinical trial of weekly vs. triweekly cisplatin-based chemotherapy concurrent with radiotherapy in the treatment of locally advanced cervical cancer. Int J Radiat Oncol Biol Phys (2011) 3.01
Association of family history with cancer recurrence and survival in patients with gastric cancer. J Clin Oncol (2012) 2.97
The association of newly identified respiratory viruses with lower respiratory tract infections in Korean children, 2000-2005. Clin Infect Dis (2006) 2.94
Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma. J Hepatol (2012) 2.94
Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer. Nat Genet (2008) 2.89
The learning curve for EMR with circumferential mucosal incision in treating intramucosal gastric neoplasm. Gastrointest Endosc (2005) 2.76
Accuracy of offspring reports of parental cardiovascular disease history: the Framingham Offspring Study. Ann Intern Med (2004) 2.74
Resumption of imatinib to control metastatic or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib (RIGHT): a randomised, placebo-controlled, phase 3 trial. Lancet Oncol (2013) 2.42
A likely explanation for the J-curve of blood pressure cardiovascular risk. Am J Cardiol (2004) 2.36
Transbronchial and transesophageal fine-needle aspiration using an ultrasound bronchoscope in mediastinal staging of potentially operable lung cancer. Chest (2010) 2.28
EBUS-centred versus EUS-centred mediastinal staging in lung cancer: a randomised controlled trial. Thorax (2013) 2.21
Management of gastric cancer in Asia: resource-stratified guidelines. Lancet Oncol (2013) 2.16
Surgical complications and the risk factors of laparoscopy-assisted distal gastrectomy in early gastric cancer. Ann Surg Oncol (2008) 2.10
Sibling cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults. JAMA (2005) 2.05
Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham Heart Study. Arterioscler Thromb Vasc Biol (2002) 2.00
Abdominal visceral adipose tissue volume is associated with increased risk of erosive esophagitis in men and women. Gastroenterology (2010) 2.00
Structure of the Bacillus subtilis quorum-sensing peptide pheromone ComX. Nat Chem Biol (2005) 1.86
Prognostic value of preoperative clinical staging assessed by computed tomography in resectable gastric cancer patients: a viewpoint in the era of preoperative treatment. Ann Surg (2010) 1.84
Current Trends of the Incidence and Pathological Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Korea 2000-2009: Multicenter Study. Cancer Res Treat (2012) 1.76
Relations of insulin sensitivity to longitudinal blood pressure tracking: variations with baseline age, body mass index, and blood pressure. Circulation (2005) 1.75
Loss of KCNJ10 protein expression abolishes endocochlear potential and causes deafness in Pendred syndrome mouse model. BMC Med (2004) 1.74
Association of parental heart failure with risk of heart failure in offspring. N Engl J Med (2006) 1.69
C-reactive protein, inflammatory conditions, and cardiovascular disease risk. Am J Med (2007) 1.64
Endoscopic submucosal dissection for metachronous tumor in the remnant stomach after distal gastrectomy. Surg Endosc (2009) 1.63
Low initial human papilloma viral load implicates worse prognosis in patients with uterine cervical cancer treated with radiotherapy. J Clin Oncol (2009) 1.56
Survival of patients with advanced hepatocellular carcinoma: sorafenib versus other treatments. J Gastroenterol Hepatol (2011) 1.55
Oncologic effectiveness of regular follow-up to detect recurrence after curative resection of gastric cancer. Ann Surg Oncol (2010) 1.54
Developing an institutional protocol guideline for laparoscopy-assisted distal gastrectomy. Ann Surg Oncol (2009) 1.51
Covered versus uncovered self-expandable metallic stents for palliation of malignant pyloric obstruction in gastric cancer patients: a randomized, prospective study. Gastrointest Endosc (2010) 1.51
Effect of repeated endoscopic screening on the incidence and treatment of gastric cancer in health screenees. Eur J Gastroenterol Hepatol (2009) 1.51
Multiple cell death pathways are independently activated by lethal hypertonicity in renal epithelial cells. Am J Physiol Cell Physiol (2013) 1.45
Association between increment of serum VEGF level and prognosis after transcatheter arterial chemoembolization in hepatocellular carcinoma patients. Cancer Sci (2008) 1.44
Gastric cancer patients at high-risk of having synchronous cancer. World J Gastroenterol (2006) 1.44
Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer. Eur J Nucl Med Mol Imaging (2005) 1.42
Technical feasibility and safety of laparoscopy-assisted total gastrectomy in gastric cancer: a comparative study with laparoscopy-assisted distal gastrectomy. J Surg Oncol (2009) 1.41